Posttranslational regulation of I-Ed by affinity for CLIP

Journal of Immunology

Volumn 179, Issue 9, 2007, Pages 5907-5915

  Rinderknecht, Cornelia H ^a   Belmares, Michael P ^a,e   Catanzarite, Tatiana L W ^a   Bankovich, Alexander J ^a,f   Holmes, Tyson H ^b   Garcia, K Christopher ^a   Nanda, Navreet K ^c   Busch, Robert ^a,g   Kovats, Susan ^d   Mellins, Elizabeth D ^a,h  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^e Arbor Vita Corporation   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g SIDNEY SUSSEX COLLEGE   (United Kingdom)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CELL LINE; CELL SURFACE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HALF LIFE TIME; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MUTANT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; WILD TYPE; ANIMAL; ANTIGEN PRESENTATION; CELL MEMBRANE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; IMMUNOLOGY; INVARIANT CHAIN; METABOLISM; MUTATION; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

B LYMPHOCYTE ANTIGEN; EPITOPE; HLA ANTIGEN CLASS 2;

ALLELES; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CELL LINE, TUMOR; CELL MEMBRANE; EPITOPES; HALF-LIFE; HISTOCOMPATIBILITY ANTIGENS CLASS II; MICE; MODELS, MOLECULAR; MUTATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

EID: 38449121239     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.9.5907     Document Type: Article

References (68)

1. Glimcher, L. H., and C. J. Kara. 1992. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10: 13-49.
2. Jones, E. Y., L. Fugger, J. L. Strominger, and C. Siebold. 2006. MHC class II proteins and disease: a structural perspective. Nat. Rev. Immunol. 6: 271-282.
3. Busch, R., C. H. Rinderknecht, S. Roh, A. W. Lee, J. J. Harding, T. Burster, T. M. Hornell, and E. D. Mellins. 2005. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression. Immunol. Rev. 207: 242-260.
4. Alfonso, C., and L. Karlsson. 2000. Nonclassical MHC class II molecules. Annu. Rev. Immunol. 18: 113-142.
5. Bikoff, E. K., R. N. Germain, and E. J. Robertson. 1995. Allelic differences affecting invariant chain dependency of MHC class II subunit assembly. Immunity 2: 301-310.
6. Hornell, T. M., T. Burster, F. L. Jahnsen, A. Pashine, M. T. Ochoa, J. J. Harding, C. Macaubas, A. W. Lee, R. L. Modlin, and E. D. Mellins. 2006. Human dendritic cell expression of HLA-DO is subset specific and regulated by maturation. J. Immunol. 176: 3536-3547.
7. Denzin, L. K., J. L. Fallas, M. Prendes, and W. Yi. 2005. Right place, right time, right peptide: DO keeps DM focused. Immunol. Rev. 207: 279-292.
8. 2O expression in primary dendritic cells. J. Immunol. 176: 3548-3556.
9. 2-O in mouse B cells and dendritic cells correlate with cell function. J. Immunol. 178: 1488-1497.
10. Liang, M. N., C. Beeson, K. Mason, and H. M. McConnell. 1995. Kinetics of the reactions between the invariant chain (85-99) peptide and proteins of the murine class II MHC. Int. Immunol. 7: 1397-1404.
11. Sette, A., S. Southwood, J. Miller, and E. Appella. 1995. Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J. Exp. Med. 181: 677-683.
12. Patil, N. S., A. Pashine, M. P. Belmares, W. Liu, B. Kaneshiro, J. Rabinowitz, H. McConnell, and E. D. Mellins. 2001. Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles. J. Immunol. 167: 7157-7168.
13. g7 molecule: rapid release of CLIP at an endosomal pH. J. Exp. Med. 189: 1723-1734.
14. Fremont, D. H., W. A. Hendrickson, P. Marrack, and J. Kappler. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science 272: 1001-1004.
15. Fremont, D. H., S. Dai, H. Chiang, F. Crawford, P. Marrack, and J. Kappler. 2002. Structural basis of cytochrome c presentation by IEk. J. Exp. Med. 195: 1043-1052.
16. Reay, P. A., R. M. Kantor, and M. M. Davis. 1994. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J. Immunol. 152: 3946-3957.
17. Sali, A., L. Potterton, F. Yuan, H. van Vlijmen, and M. Karplus. 1995. Evaluation of comparative protein modeling by MODELLER. Proteins 23: 318-326.
18. DeLano, W. L. 2002. The PyMOL Molecular Graphics System. DeLano Scientific, Palo Alto, CA.
19. Kim, K. J., C. Kanellopoulos-Langevin, R. M. Merwin, D. H. Sachs, and R. Asofsky. 1979. Establishment and characterization of BALB/c lymphoma lines with B cell properties. J. Immunol. 122: 549-554.
20. Dang, L. H., L. L. Lien, B. Benacerraf, and K. L. Rock. 1993. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation. J. Immunol. 150: 4206-4217.
21. d mouse cell lines are caused by point mutations in the H2-DMa gene. Eur. J. Immunol. 29: 905-911.
22. Germain, R. N., and H. Quill. 1986. Unexpected expression of a unique mixed-isotype class II MHC molecule by transfected L-cells. Nature 320: 72-75.
23. Nanda, N. K., and A. J. Sant. 2000. DM determines the cryptic and immunodominant fate of T cell epitopes. J. Exp. Med. 192: 781-788.
24. Ozato, K., N. M. Mayer, and D. H. Sachs. 1982. Monoclonal antibodies to mouse major histocompatibility complex antigens. Transplantation 34: 113-120.
25. Sant, A. J., L. R. Hendrix, J. E. Coligan, W. L. Maloy, and R. N. Germain. 1991. Defective intracellular transport as a common mechanism limiting expression of inappropriately paired class II major histocompatibility complex α/β chains. J. Exp. Med. 174: 799-808.
26. Doebele, R. C., R. Busch, H. M. Scott, A. Pashine, and E. D. Mellins. 2000. Determination of the HLA-DM interaction site on HLA-DR molecules. Immunity 13: 517-527.
27. Holm, S. 1979. A simple sequentially rejective multiple test procedure. Scand. J. Stat. 6: 65-70.
28. Asaithambi, N. S. 1995. Numerical Analysis: Theory and Practice. Saunders College Publishing, Fort Worth.
29. Rice, J. A. 1995. Mathematical Statistics and Data Analysis. Duxbury Press, Belmont.
30. McCulloch, C. E., and S. R. Searle. 2001. Generalized, Linear, and Mixed Models. John Wiley and Sons, New York.
31. Liang, K. Y., and S. L. Zeger. 1986. Longitudinal analysis using generalized linear models. Biometrika 73: 13-22.
32. Rammensee, H. G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41: 178-228.
33. Rammensee, H., J. Bachmann, N. P. Emmerich, O. A. Bachor, and S. Stevanovic. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50: 213-219.
34. Schild, H., U. Grüneberg, G. Pougialis, H. J. Wallny, W. Keilholz, S. Stevanovic, and H. G. Rammensee. 1995. Natural ligand motifs of H-2E molecules are allele specific and illustrate homology to HLA-DR molecules. Int. Immunol. 7: 1957-1965.
35. Doebele, R. C., A. Pashine, W. Liu, D. M. Zaller, M. Belmares, R. Busch, and E. D. Mellins. 2003. Point mutations in or near the antigen-binding groove of HLA-DR3 implicate class II-associated invariant chain peptide affinity as a constraint on MHC class II polymorphism. J. Immunol. 170: 4683-4692.
36. 2-O influence on antigen presentation in H2-E-expressing mice. Eur. J. Immunol. 33: 2014-2021.
37. McFarland, B. J., and C. Beeson. 2002. Binding interactions between peptides and proteins of the class II major histocompatibility complex. Med. Res. Rev. 22: 168-203.
38. Dadaglio, G., C. A. Nelson, M. B. Deck, S. J. Petzold, and E. R. Unanue. 1997. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity 6: 727-738.
39. Mellins, E., B. Arp, D. Singh, B. Carreno, L. Smith, A. H. Johnson, and D. Pious. 1990. Point mutations define positions in HLA-DR3 molecules that affect antigen presentation. Proc. Natl. Acad. Sci. USA 87: 4785-4789.
40. Chang, S. T., J. J. Linderman, and D. E. Kirschner. 2005. Multiple mechanisms allow Mycobacterium tuberculosis to continuously inhibit MHC class II-mediated antigen presentation by macrophages. Proc. Natl. Acad. Sci. USA 102: 4530-4535.
41. Kersh, G. J., M. J. Miley, C. A. Nelson, A. Grakoui, S. Horvath, D. L. Donermeyer, J. Kappler, P. M. Allen, and D. H. Fremont. 2001. Structural and functional consequences of altering a peptide MHC anchor residue. J. Immunol. 166: 3345-3354.
42. Germain, R. N. 1995. Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function. Semin. Immunol. 7: 361-372.
43. Rabinowitz, J. D., M. Vrljic, P. M. Kasson, M. N. Liang, R. Busch, J. J. Boniface, M. M. Davis, and H. M. McConnell. 1998. Formation of a highly peptide-receptive state of class II MHC. Immunity 9: 699-709.
44. Germain, R. N., and A. G. Rinker, Jr. 1993. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules. Nature 363: 725-728.
45. Nelson, C. A., S. J. Petzold, and E. R. Unanue. 1994. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 371: 250-252.
46. Agrawal, B., E. Fraga, K. Kane, and B. Singh. 1994. Up-regulation of the MHC class II molecules on B cells by peptide ligands. J. Immunol. 152: 965-975.
47. Zhong, G., F. Castellino, P. Romagnoli, and R. N. Germain. 1996. Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP). J. Exp. Med. 184: 2061-2066.
48. Germain, R. N., and L. R. Hendrix. 1991. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353: 134-139.
49. Ceman, S., S. Wu, T. S. Jardetzky, and A. J. Sant. 1998. Alteration of a single hydrogen bond between class II molecules and peptide results in rapid degradation of class II molecules after invariant chain removal. J. Exp. Med. 188: 2139-2149.
50. Guerra, C. B., R. Busch, R. C. Doebele, W. Liu, T. Sawada, W. W. Kwok, M. D. Chang, and E. D. Mellins. 1998. Novel glycosylation of HLA-DR α disrupts antigen presentation without altering endosomal localization. J. Immunol. 160: 4289-4297.
51. Neefjes, J. J., V. Stollorz, P. J. Peters, H. J. Geuze, and H. L. Ploegh. 1990. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 61: 171-183.
52. Kropshofer, H., S. O. Arndt, G. Moldenhauer, G. J. Hammerling, and A. B. Vogt. 1997. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 6: 293-302.
53. Liang, M. N., C. Lee, Y. Xia, and H. M. McConnell. 1996. Molecular modeling and design of invariant chain peptides with altered dissociation kinetics from class II MHC. Biochemistry 35: 14734-14742.
54. Honey, K., K. Forbush, P. E. Jensen, and A. Y. Rudensky. 2004. Effect of decreasing the affinity of the class II-associated invariant chain peptide on the MHC class II peptide repertoire in the presence or absence of H-2M. J. Immunol. 172: 4142-4150.
55. Gautam, A. M., M. Yang, P. J. Milburn, R. Baker, A. Bhatnagar, J. McCluskey, and T. Boston. 1997. Identification of residues in the class II-associated Ii peptide (CLIP) region of invariant chain that affect efficiency of MHC class II-mediated antigen presentation in an allele-dependent manner. J. Immunol. 159: 2782-2788.
56. Ridgway, W. M., M. Fasso, and C. G. Fathman. 1999. A new look at MHC and autoimmune disease. Science 284: 749-751.
57. Nepom, G. T., and W. W. Kwok. 1998. Molecular basis for HLA-DQ associations with IDDM. Diabetes 47: 1177-1184.
58. + regulatory T-cell selection. Immunol. Rev. 212: 74-85.
59. Parak, W. J., S. Dannohl, M. George, M. K. Schuler, J. Schaumburger, H. E. Gaub, O. Muller, and W. K. Aicher. 2000. Metabolic activation stimulates acid production in synovial fibroblasts. J. Rheumatol. 27: 2312-2322.
60. Wilkins, R. J., and A. C. Hall. 1995. Control of matrix synthesis in isolated bovine chondrocytes by extracellular and intracellular pH. J. Cell. Physiol. 164: 474-481.
61. Radu, C. G., A. Nijagal, J. McLaughlin, L. Wang, and O. N. Witte. 2005. Differential proton sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and G2A expressed in immune cells. Proc. Natl. Acad. Sci. USA 102: 1632-1637.
62. Ng, A. W., A. Bidani, and T. A. Heming. 2004. Innate host defense of the lung: effects of lung-lining fluid pH. Lung 182: 297-317.
63. Muczynski, K. A., S. K. Anderson, and D. Pious. 1998. Discoordinate surface expression of IFN-γ-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization. J. Immunol. 160: 3207-3216.
64. Douek, D. C., and D. M. Altmann. 1997. HLA-DO is an intracellular class II molecule with distinctive thymic expression. Int. Immunol. 9: 355-364.
65. + regulatory T cells in human thymus. Nature 436: 1181-1185.
66. Rohn, T. A., M. Boes, D. Wolters, S. Spindeldreher, B. Muller, H. Langen, H. Ploegh, A. B. Vogt, and H. Kropshofer. 2004. Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization. Nat. Immunol. 5: 909-918.
67. Brown, D. R., K. Swier, N. H. Moskowitz, M. F. Naujokas, R. M. Locksley, and S. L. Reiner. 1997. T helper subset differentiation in the absence of invariant chain. J. Exp. Med. 185: 31-41.
68. Chaturvedi, P., R. Hengeveld, M. A. Zechel, E. Lee-Chan, and B. Singh. 2000. The functional role of class II-associated invariant chain peptide (CLIP) in its ability to variably modulate immune responses. Int. Immunol. 12: 757-765.